qz
Vertex Pharmaceuticals is buying Crinetics to expand into rare hormonal diseases

The deal gives Vertex access to Palsonify, an oral acromegaly treatment, and atumelnant, a late-stage drug for congenital adrenal hyperplasia [...]

Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

venturebeat
Claude Code, Copilot and Codex all got hacked. Every attacker went for the credential, not the model.

On March 30, BeyondTrust proved that a crafted GitHub branch name could steal Codex’s OAuth token in cleartext. OpenAI classified it Critical P1. Two days later, Anthropic’s Claude Code source cod [...]

Match Score: 56.27

venturebeat
Google Cloud takes aim at CoreWeave and AWS with managed Slurm for enterprise-scale AI training

Some enterprises are best served by fine-tuning large models to their needs, but a number of companies plan to build their own models, a project that would require access to GPUs. Google Cloud wants [...]

Match Score: 55.88

thenextweb
How an AI system beat experienced doctors at diagnosing rare diseases

DeepRare, an agentic AI system integrating 40 specialised tools, outperformed medical specialists in identifying rare conditions in a head-to-head study published in Nature. For millions of people wit [...]

Match Score: 49.38

venturebeat
Agent context layers: Enterprises governing their AI data are catching twice as many bad answers as the ones who aren't

Across 101 enterprises, the context feeding AI agents is failing often and repeatedly. Sixty-eight percent have traced a confident but wrong agent answer to missing or inconsistent business context in [...]

Match Score: 46.38

Destination
New U.S. drug prices doubled amid shift towards treating rare diseases

New drugs being explicitly developed to treat rare diseases are getting more expensive.Read more... [...]

Match Score: 43.21

Destination
Anthropic launches its own drug discovery programs to tackle diseases Big Pharma considers unprofitable

Anthropic is launching its own drug development program for neglected diseases that the pharmaceutical industry considers unprofitable. Novartis CEO Vas Narasimhan thinks AI could cut development time [...]

Match Score: 38.58

Destination
Apple commits $500 million over several years to buy US-made rare earth magnets

Apple just announced a commitment of $500 million over several years to buy rare earth magnets from the US-based company MP Materials. These rare earth magnets are used in a number of products, includ [...]

Match Score: 37.03

thenextweb
Alibaba will pay 600 million dollars to settle a US probe into illegal pharmaceutical sales on its platform

Alibaba and its US digital payment processor have agreed to pay 600 million dollars to resolve a federal investigation into whether they failed to prevent the sale and importation of illegal pharmaceu [...]

Match Score: 33.11

Destination
Nanoscope Therapeutics CEO Sulagna Bhattacharya on tackling rare eye diseases

Nanoscope Therapeutics CEO Sulagna Bhattacharya discusses how the company is tackling rare eye diseases [...]

Match Score: 32.40